Annual CFF
$154.00 K
-$46.00 K-23.00%
December 31, 2023
Summary
- As of February 7, 2025, NXTC annual cash flow from financing activities is $154.00 thousand, with the most recent change of -$46.00 thousand (-23.00%) on December 31, 2023.
- During the last 3 years, NXTC annual CFF has risen by +$1.57 million (+110.88%).
- NXTC annual CFF is now -99.94% below its all-time high of $243.04 million, reached on December 31, 2019.
Performance
NXTC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1000.00
-$105.00 K-99.06%
September 30, 2024
Summary
- As of February 7, 2025, NXTC quarterly cash flow from financing activities is $1000.00, with the most recent change of -$105.00 thousand (-99.06%) on September 30, 2024.
- Over the past year, NXTC quarterly CFF has dropped by -$70.00 thousand (-98.59%).
- NXTC quarterly CFF is now -100.00% below its all-time high of $161.31 million, reached on December 31, 2019.
Performance
NXTC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$179.00 K
+$1000.00+0.56%
September 30, 2024
Summary
- As of February 7, 2025, NXTC TTM cash flow from financing activities is $179.00 thousand, with the most recent change of +$1000.00 (+0.56%) on September 30, 2024.
- Over the past year, NXTC TTM CFF has increased by +$25.00 thousand (+16.23%).
- NXTC TTM CFF is now -99.93% below its all-time high of $243.04 million, reached on December 31, 2019.
Performance
NXTC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NXTC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.0% | -98.6% | +16.2% |
| 3 y3 years | +110.9% | +100.0% | +104.7% |
| 5 y5 years | -99.9% | +100.9% | -99.9% |
NXTC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.0% | +104.7% | -99.2% | -100.0% | -31.7% | +105.5% |
| 5 y | 5-year | -99.9% | +104.7% | -100.0% | +100.0% | -99.9% | +104.7% |
| alltime | all time | -99.9% | +104.7% | -100.0% | +100.0% | -99.9% | +104.7% |
NextCure Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1000.00(-99.1%) | $179.00 K(+0.6%) |
| Jun 2024 | - | $106.00 K(>+9900.0%) | $178.00 K(+14.8%) |
| Mar 2024 | - | $1000.00(-98.6%) | $155.00 K(+0.6%) |
| Dec 2023 | $154.00 K(-23.0%) | $71.00 K(>+9900.0%) | $154.00 K(+6.9%) |
| Sep 2023 | - | $0.00(-100.0%) | $144.00 K(0.0%) |
| Jun 2023 | - | $83.00 K(>+9900.0%) | $144.00 K(+2.9%) |
| Mar 2023 | - | $0.00(-100.0%) | $140.00 K(-30.0%) |
| Dec 2022 | $200.00 K(-106.1%) | $61.00 K(>+9900.0%) | $200.00 K(-23.7%) |
| Sep 2022 | - | $0.00(-100.0%) | $262.00 K(-111.1%) |
| Jun 2022 | - | $79.00 K(+31.7%) | -$2.37 M(-16.9%) |
| Mar 2022 | - | $60.00 K(-51.2%) | -$2.85 M(-12.7%) |
| Dec 2021 | -$3.27 M | $123.00 K(-104.7%) | -$3.27 M(-13.8%) |
| Sep 2021 | - | -$2.63 M(+551.0%) | -$3.79 M(+149.2%) |
| Jun 2021 | - | -$404.00 K(+14.1%) | -$1.52 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$354.00 K(-11.1%) | -$1.53 M(+8.1%) |
| Dec 2020 | -$1.42 M(-100.6%) | -$398.00 K(+9.6%) | -$1.42 M(-100.9%) |
| Sep 2020 | - | -$363.00 K(-12.3%) | $160.29 M(-0.2%) |
| Jun 2020 | - | -$414.00 K(+72.5%) | $160.54 M(-33.1%) |
| Mar 2020 | - | -$240.00 K(-100.1%) | $239.83 M(-1.3%) |
| Dec 2019 | $243.04 M(+100.2%) | $161.31 M(<-9900.0%) | $243.04 M(+40.9%) |
| Sep 2019 | - | -$112.00 K(-100.1%) | $172.47 M(+0.0%) |
| Jun 2019 | - | $78.88 M(+2555.8%) | $172.46 M(+38.5%) |
| Mar 2019 | - | $2.97 M(-96.7%) | $124.49 M(+2.5%) |
| Dec 2018 | $121.42 M(+388.4%) | $90.73 M(<-9900.0%) | $121.42 M(+295.7%) |
| Sep 2018 | - | -$114.00 K(-100.4%) | $30.69 M(-0.4%) |
| Jun 2018 | - | $30.90 M(<-9900.0%) | $30.80 M(<-9900.0%) |
| Mar 2018 | - | -$100.00 K | -$100.00 K |
| Dec 2017 | $24.86 M | - | - |
FAQ
- What is NextCure annual cash flow from financing activities?
- What is the all time high annual CFF for NextCure?
- What is NextCure annual CFF year-on-year change?
- What is NextCure quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for NextCure?
- What is NextCure quarterly CFF year-on-year change?
- What is NextCure TTM cash flow from financing activities?
- What is the all time high TTM CFF for NextCure?
- What is NextCure TTM CFF year-on-year change?
What is NextCure annual cash flow from financing activities?
The current annual CFF of NXTC is $154.00 K
What is the all time high annual CFF for NextCure?
NextCure all-time high annual cash flow from financing activities is $243.04 M
What is NextCure annual CFF year-on-year change?
Over the past year, NXTC annual cash flow from financing activities has changed by -$46.00 K (-23.00%)
What is NextCure quarterly cash flow from financing activities?
The current quarterly CFF of NXTC is $1000.00
What is the all time high quarterly CFF for NextCure?
NextCure all-time high quarterly cash flow from financing activities is $161.31 M
What is NextCure quarterly CFF year-on-year change?
Over the past year, NXTC quarterly cash flow from financing activities has changed by -$70.00 K (-98.59%)
What is NextCure TTM cash flow from financing activities?
The current TTM CFF of NXTC is $179.00 K
What is the all time high TTM CFF for NextCure?
NextCure all-time high TTM cash flow from financing activities is $243.04 M
What is NextCure TTM CFF year-on-year change?
Over the past year, NXTC TTM cash flow from financing activities has changed by +$25.00 K (+16.23%)